Advertisement

Introducing the Measurement of Quality of Life into Clinical Practice: Technology and Mechanisms

  • R. Sanders
  • G. Velikova
  • A. Smith
  • D. Stark
  • E. P. Wright
  • J. Randerson Moor
  • D. T. Bishop
  • P. Selby
Conference paper

Abstract

Health-related quality of life (QL) is a recognised and important patient-related outcome of anti-cancer treatment, which can be measured by carefully developed, psychometrically robust, questionnaires. Although the validity and sensitivity of the cancer QL questionnaires is now widely accepted and they are frequently used in therapeutic clinical trials, they have yet to impact fully on patients’ care and are little used by practising oncologists. Several barriers have hampered the practical use of QL measures for individual patients, including the logistic barrier of collection and analysis of large amounts of data, the conceptual barrier of determining the clinical meaning of QL scores, the theoretical concerns over whether instruments developed for group comparisons can be used for individual patients, and the lack of research data on the possible benefits for individual patients. Thus, whilst oncology professionals are broadly convinced of the value of the concept and measurement of QL and its utilisation in clinical trials is increasing, its impact on routine clinical practice remains small.

Keywords

Panic Disorder Touch Screen Generalise Anxiety Disorder Serotonin Transporter Gene Phobic Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lohr KN. Applications of health status assessment measures in clinical practice: Overview of the third conference on advances in health status measurement. Med. Care 1992;30:MS1–MS14 (suppl. 5).Google Scholar
  2. 2.
    Lohr KN. Advances in health status assessment: Overview of the conference. Med.Care 1989;27:S1–S11 (suppl. 3).PubMedCrossRefGoogle Scholar
  3. 3.
    Aaronson NK, Ahmedzai S, Bergman B et al. The European Organisation for Research and Treatment of Cancer QLQC30: A quality of life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 1993;85:365–376.PubMedCrossRefGoogle Scholar
  4. 4.
    Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Velikova G, Wright EP, Smith AB et al. Automated collection of quality of life data: A comparison of paper and computer touch-screen questionnaires. J. Clin. Oncol. 1999;17:998–1007.PubMedGoogle Scholar
  6. 6.
    Wright EP, Selby PJ, Gillibrand A et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. Submitted to J. Clin. Oncol.Google Scholar
  7. 7.
    Berwick DM, Murphy JM, Goldman PA, Ware JE, Barsky AJ, Weinstein MC. Performance of a five item mental health screening test. Med. Care 1991;29:169–176.PubMedCrossRefGoogle Scholar
  8. 8.
    Harrison J, Maguire P, Ibbotson T, Macleod R, Hopwood P. Concerns, confiding and psychiatric disorder in newly diagnosed cancer patients: A descriptive study. Psycho-Oncology 1994;3:173–9.CrossRefGoogle Scholar
  9. 9.
    Wing JK, Cooper J, Sartorious N. Measurement and classification of psychiatric symptoms. Cambridge University Press, Cambridge, 1974.Google Scholar
  10. 10.
    Cull A, Gould A, House A et al. Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Submitted to Br. J. Cancer.Google Scholar
  11. 11.
    Velikova G, Wright EP, Smith AB et al. Self-reported quality of life of individual cancer patients: Concordance of results with disease course and medical records. J. Clin. Oncol. 2001;19:2064–2073PubMedGoogle Scholar
  12. 12.
    McQuellon RP, Andrykowski M. Psychological complications of hematopoietic stem cell transplantation. In: Clinical bone marrow and blood stem cell transplantation. K Atkinson (Ed) Cambridge University Press, Cambridge, 2000.Google Scholar
  13. 13.
    Massie MJ, Popkin MK. Depressive disorders In: Psycho-oncology, JC Holland (Ed), Oxford University Press, 1998.Google Scholar
  14. 14.
    Bukberg J, Penman D, Holland JC. Depression in hospitalised cancer patients. Psychosom. Med. 1984;46:199–212.PubMedGoogle Scholar
  15. 15.
    Plumb M, Holland JC. Comparative studies of psychological function in patients with advanced cancer I: Self-reported depressive symptoms . Psychosom. Med. 1977;39:264–276.PubMedGoogle Scholar
  16. 16.
    Craig TJ, Abeloff MD. Psychiatric symptomatology among hospitalised cancer patients. Am. J. Psychiatry 1974;131:1323–1327.PubMedGoogle Scholar
  17. 17.
    Noyes RN, Holt CS, Massie MJ. Anxiety disorders In: Psycho-oncology, JC Holland (Ed), Oxford University Press, 1998.Google Scholar
  18. 18.
    Stark DPH, House A. Anxiety in cancer patients. Br. J. Cancer 2000; 83:1261–1267.PubMedCrossRefGoogle Scholar
  19. 19.
    McGuffin P, Katz R, Watkins S, Rutherford J. A hospital based twin register of the heritability of DSM-IV unipolar depression. Arch. Gen. Psychiatry 1996;53:129–136.PubMedCrossRefGoogle Scholar
  20. 20.
    Kendler KS, Prescott CA. A population based twin study of lifetime major depression in men and women . Arch. Gen. Psychiatry 1999;56:39–44;correction 57:94–95.PubMedCrossRefGoogle Scholar
  21. 21.
    Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and metaanalysis. Am. J. Psychiatry 2000;157:1552–1562.PubMedCrossRefGoogle Scholar
  22. 22.
    Oruc L, Verheyen GR, Furac I et al. Positive association between the GABRA5 gene and unipolar recurrent major depression. Neuropsychobiology 1997;36:62–64.PubMedCrossRefGoogle Scholar
  23. 23.
    Ogilvie A, Battersby S, Bubb VJ et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996;347:731–733.PubMedCrossRefGoogle Scholar
  24. 24.
    Collier DA, Stober G, Heils A et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1996;1:453–460.PubMedGoogle Scholar
  25. 25.
    Crowe RR, Noyes R, Pauls DL, Slymen D. A family study of panic disorder. Arch. Gen. Psychiatry 1983;40:1065–1069.PubMedCrossRefGoogle Scholar
  26. 26.
    Fyer AJ, Mannuzza S, Chapman T, Lipsitz J, Martin L, Klein D. Panic disorder and social phobia: Effects of comorbidity on familial transmission. Anxiety 1996;2:173-178.PubMedCrossRefGoogle Scholar
  27. 27.
    Fyer AJ, Mannuzza S, Gallops S et al. Familial transmission of simple phobias and fears. Arch. Gen. Psychiatry 1990;47:252–256.PubMedCrossRefGoogle Scholar
  28. 28.
    Stein MB, Chartier MJ, Hazen AL et al. A direct interview family study of generalised social phobia. Am. J. Psychiatry 1998; 155:90–97.PubMedGoogle Scholar
  29. 29.
    Smoller JW, Tsuang MT. Panic and phobic anxiety: Defining phenotypes for genetic studies. Am. J. Psychiatry 1998; 155:1152–1162.PubMedGoogle Scholar
  30. 30.
    Noyes R, Crowe RR, Harris EL, Hampa BJ, McChesney CM, Chaudry DR. Relationship between panic disorder and agoraphobia: A family study. Arch. Gen. Psychiatry 1986;43:227–232PubMedCrossRefGoogle Scholar
  31. 31.
    Mendlewicz J, Papadimitriou G, Wilmotte J. Family study of panic disorder: A comparison with generalised anxiety disorder, major depression and normal subjects. Psychiatr. Genet. 1993;3:73–78CrossRefGoogle Scholar
  32. 32.
    Maier W, Minges J & Lichtermann D. The familial relationship between panic disorder and unipolar depression. J. Psychiatr. Res. 1995;29:375–388.PubMedCrossRefGoogle Scholar
  33. 33.
    Kendler KS, Neale MC, Kessler RC, Heath A, Eaves L. The genetic epidemiology of phobias in women. Arch. Gen. Psychiatry 1992;49:273–281.PubMedCrossRefGoogle Scholar
  34. 34.
    Kendler KS, Neale MC, Kessler RC, Heath A, Eaves LJ. Panic disorder in women: A population based twin study. Psychol Med. 1993;23:397–406.PubMedCrossRefGoogle Scholar
  35. 35.
    Kendler KS, Pedersen NL, Neale MC, Mathe A. A pilot Swedish twin study of affective illness including hospital- and population-ascertained subsamples: Results of model fitting. Behav. Genet. 1995;25:217–232.PubMedCrossRefGoogle Scholar
  36. 36.
    Deckert J, Nothen MM, Franke P et al. Systematic mutation screening and association study of the Aj and A2A adenosine receptor genes in panic disorder suggest a contribution of the A2A gene to the development of disease. Mol. Psychiatry 1998;3:81–85.PubMedCrossRefGoogle Scholar
  37. 37.
    Deckert J, Catalano M, Syagailo YV et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 1999;8:621–624.PubMedCrossRefGoogle Scholar
  38. 38.
    Smoller J, Acierno JS, Rosenbaum JF et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am. J. Med. Genet. (Neuropsychiatrie Genetics) 2001;105:195–206.CrossRefGoogle Scholar
  39. 39.
    Weissman M, Fyer A, Haghighi F et al. Potential panic disorder syndrome: Clinical and genetic linkage evidence. Am. J. Med. Genet. (Neuropsychiatrie Genetics) 2000;96:24–35.CrossRefGoogle Scholar
  40. 40.
    Comings DE, Muhleman D, Johnson P, MacMurray JP. Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol. Psychiatry 1999;4:372–377.Google Scholar
  41. 41.
    Jorm AF, Prior M, Sanson A, Smart D, Zhang Yorkgate, Eateal S. Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behaviour problems in children: A longitudinal study from infancy to the mid-teens. Mol. Psychiatry 2000;5:542–547.PubMedCrossRefGoogle Scholar
  42. 42.
    Sander T, Harms H, Dufeu P et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol. Psychiatry 1998;43:908–12PubMedCrossRefGoogle Scholar
  43. 43.
    Schuckit MA, Mazzanti C, Smith TL et al. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol. Psychiatry 1999;45:647–651.PubMedCrossRefGoogle Scholar
  44. 44.
    Coyle N, Jones I, Robertson E, Lendon C, Craddock N. Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. Lancet 2000;356:1490–1. 1998;81:58–63.PubMedCrossRefGoogle Scholar
  45. 45.
    Spencer SM, Carver CS Price AA Psychological and social factors in adaptation. In: Psycho-oncology, JC Holland (Ed), Oxford University Press, 1998Google Scholar
  46. 46.
    Bellivier, F, Henry C,k Szoke A t al. Serotonin transporter gene polymorphisms in patients with unipolr or bipolar depression. Neurosci Lett 1998;255:143–6PubMedCrossRefGoogle Scholar
  47. 47.
    Furlong RA Ho L, Walsh C et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 1998;81:58–63PubMedCrossRefGoogle Scholar
  48. 48.
    Lesch K-P, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–1531.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2002

Authors and Affiliations

  • R. Sanders
    • 1
  • G. Velikova
    • 1
  • A. Smith
    • 1
  • D. Stark
    • 1
  • E. P. Wright
    • 1
  • J. Randerson Moor
    • 1
  • D. T. Bishop
    • 1
  • P. Selby
    • 1
  1. 1.Imperial Cancer Research Fund Clinical Centre in LeedsCancer Research Building St James’s University HospitalLeedsUK

Personalised recommendations